Re-evaluating Methods for Assessing Differences in Response in Ileal vs. Colonic Crohn's Disease: A Post-hoc Analysis of the FITZROY Trial.

Christopher MaBrian G FeaganZhongya WangGuangyong ZouMichelle I SmithLisa M ShackeltonBruce E SandsRemo PanaccioneGeert R D'HaensSéverine VermeireVipul Jairath

Published in: Journal of Crohn's & colitis (2024)

Filgotinib demonstrated similar efficacy in ileal-dominant and isolated colonic CD when controlling for baseline disease activity and clustering effects.

Keyphrases

disease activity
rheumatoid arthritis
systemic lupus erythematosus
rheumatoid arthritis patients
ankylosing spondylitis
ulcerative colitis
juvenile idiopathic arthritis
clinical trial
phase iii
single cell
phase ii
rna seq
randomized controlled trial
nk cells
placebo controlled